Zhang, W., Zhang, W., Zhang, W., Zhao, X., Zhao, X., Zhao, X., . . . Yu, H. Conversion study of hepatocellular carcinoma using HAIC combined with lenvatinib and PD-1/L1 immunotherapy under the guidance of BCLC staging. Frontiers Media S.A.
Chicago Style (17th ed.) CitationZhang, Weihao, et al. Conversion Study of Hepatocellular Carcinoma Using HAIC Combined with Lenvatinib and PD-1/L1 Immunotherapy Under the Guidance of BCLC Staging. Frontiers Media S.A.
MLA (9th ed.) CitationZhang, Weihao, et al. Conversion Study of Hepatocellular Carcinoma Using HAIC Combined with Lenvatinib and PD-1/L1 Immunotherapy Under the Guidance of BCLC Staging. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.